financial interest disclosure
play

Financial Interest Disclosure LPI: Theres No Harm in Waiting and - PowerPoint PPT Presentation

Financial Interest Disclosure LPI: Theres No Harm in Waiting and Observing Research Affiliation Advisory Boards Allergan, Inc. Allergan Shan Lin, MD Memantine Study Iridex National Eye Institute Professor


  1. Financial Interest Disclosure LPI: There’s No Harm in Waiting and Observing • Research Affiliation • Advisory Boards • Allergan, Inc. • Allergan Shan Lin, MD • Memantine Study • Iridex • National Eye Institute Professor Director, Glaucoma Service • OHTS study • Carl Zeiss Meditec Dept. of Ophthalmology • Visante OCT study UCSF School of Medicine • Genentech • Lucentis/Ahmed valve Koret Vision Center study UCSF Medical School LPI for PACS Angle Closure Disease • Why you shouldn’t do LPI • Primary Angle Closure Suspect (PACS) • Occludable angle • NO evidence LPI reduces risk for glaucoma • No PAS • Natural history of PACS mostly benign • Primary Angle Closure (PAC) • May cause significant side effects • Occludable angle • Later Phaco obviates the need for LPI • PAS +/- OHTN • Primary Angle Closure Glaucoma (PACG) • Angle closure • Optic nerve +/- VF damage 1

  2. PACS Foster Definition • What defines PACS and when should you do LPI? • Foster definition: ≥ 270 degrees of ant TM or less • AAO definition: ≥ 180 degrees of ant TM or less Foster PJ et al. Br J Ophthalmol. 2002;86:238-242 What is the Risk for Glaucoma What is the Risk for Glaucoma in PACS? in PACS? • PACS Progression in a Population Study • 50 PACS cases • 11 (22%) � Primary Angle Closure (PAC) • Vellore Eye Study (India) • NONE � PACG • N=972 patients • PACS=118 patients • 10.5% of eyes • 5 year follow up � 50 PACS cases Thomas R et al. Br J Ophthalmol 2003;87:450-454 Thomas R et al. Br J Ophthalmol 2003;87:450-454 2

  3. Should You Do LPI? Should You Do LPI? Thomas R et al. Br J Ophthalmol 2003;87:450-454 Thomas R et al. Br J Ophthalmol 2003;87:450-454 20% do not respond to prophylactic LPI What You Should Do Who likely NOT respond to LPI? • Larger angle (AOD) • More anterior iris insertion (SS-IR: 0.085 vs 0.125mm) • Thicker peripheral iris (0.447 vs 0.415 mm) • More CB anterior rotation (TCPD: 0.514 vs 0.562mm) Lee R…Lin S. IOVS 2013 Huang G…Lin S. Curr Eye Res 2012 Jul;37(7):575-82 Thomas R et al. Br J Ophthalmol 2003;87:450-454 Lee R…Lin S. Ophthalmology 2014 Jun;121(6):1194-202 He M Ophthalmology 2007 3

  4. Side effects of LPI • Variety of visual symptoms •775 bilateral PACS were • haloes, shadows, glare, crescents randomized • linear dysphotopsia (the most specific and •LPI one eye • Untreated fellow eye as problematic symptom) control •Angle width of treated eyes • 2.7% to 6.8% of patients after LPI Angle width (degree) AOD250 ( µ m) •increased markedly after LPI • Monocular diplopia •remained stable for 6 • IOP rise, transient uveitis, hyphema months •decreased significantly by • Corneal trauma, cataract, closure of the iridotomy, 18 months •Untreated eyes retinal detachment •consistent and rapid decrease in angle width over the 18 months. ARA ( µ m) TISA500 ( µ m) Am J Ophthalmol 2014;157:929–935 Jiang, He, Ophthalmology 2014 Additional IOP-lowering interventions Phaco Effect in Narrow Angles after LPI • Peng et al. 356 Vietnamese patients, 12 years • PACS 7% needed additional therapy • PAC 42% needed additional therapy • PACG 100% needed additional therapy • Rosman et al. CACG in New York and Asia, 56 months • 41% topical glaucoma medication • 31% underwent filtering surgery • 28% underwent a glaucoma laser procedure Peng P H…Lin S. Br J Ophthalmol, 2011 Bansal S, et al. Am J Ophthalmol, 2015 Rosman M, et al. Ophthalmology, 2002 Blondeau P, et al. Can J Ophthalmol, 2011 Huang G…Lin S. Arch Ophthalmol 2011;129(10):1283-90 4

  5. AOD Change Summary Narrow angle group Open angle group P Value 0.179 ± 0.014 0.297 ± 0.019 AOD500(mm),Nasal 0.399 ± 0.017 0.427 ± 0.019 Preoperative <0.001* • NO evidence that LPI is effective in 0.405 ± 0.024 0.452 ± 0.014 10 days 0.021* preventing progression compared to No LPI 0.403 ± 0.024 0.452 ± 0.017 1 month 0.005* 0.389 ± 0.025 0.451 ± 0.015 3 months 0.008* • Side effects of LPI not insignificant 6 months 0.002* • Future Phaco for cataract obviates LPI 0.215 ± 0.018 0.129 ± 0.024 Changes in AOD500(mm),Nasal 0.215 ± 0.019 0.154 ± 0.020 10 days 0.217 ± 0.023 0.156 ± 0.020 1 month 0.003* 0.196 ± 0.023 0.155 ± 0.021 3 months 6 months AOD500= angle opening distance at 500 µ m anterior to the scleral spur *Statistically significant from linear mixed model Huang G…Lin S. Arch Ophthalmol 2011;129(10):1283-90 5

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend